The treatment with pyridostigmine improves the cardiocirculatory function in rats with chronic heart failure

Autonomic Neuroscience: Basic and Clinical

Volumn 173, Issue 1-2, 2013, Pages 58-64

  Sabino, João Paulo J ^a   da Silva, Carlos Alberto Aguiar ^a   de Melo, Rubens Fernando ^a   Fazan Jr , Rubens ^a   Salgado, Helio C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autonomic cardiovascular control; Baroreflex; Cardiac function; Heart rate variability

Indexed keywords

PYRIDOSTIGMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BEZOLD JARISCH REFLEX; CARDIOVASCULAR PARAMETERS; CONGESTIVE HEART FAILURE; DRUG MECHANISM; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART PERFORMANCE; HEART RATE; HEART RHYTHM; HYPOTENSION; MALE; NONHUMAN; PARASYMPATHETIC FUNCTION; PRESSORECEPTOR; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PULSE INTERVAL; RAT; SYMPATHETIC FUNCTION;

ANIMALS; BAROREFLEX; CARDIOTONIC AGENTS; CHOLINESTERASE INHIBITORS; CORONARY CIRCULATION; CORONARY STENOSIS; CORONARY VESSELS; EVOKED POTENTIALS; HEART; HEART FAILURE; HEART RATE; LIGATION; MALE; MYOCARDIUM; PARASYMPATHETIC NERVOUS SYSTEM; PYRIDOSTIGMINE BROMIDE; RANDOM ALLOCATION; RATS; RATS, WISTAR; SYMPATHETIC NERVOUS SYSTEM;

EID: 84871516613     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2012.11.007     Document Type: Article

References (53)

1. Andrade T.U., Pinto V.D., Medeiros A.R., Abreu G.R., Moysés M.R., Sampaio K.N., Bissoli N.S. Effect of enalapril treatment on the sensitivity of cardiopulmonary reflexes in rats with myocardial infarction. Clin. Exp. Pharmacol. Physiol. 2007, 34:606-611.
2. Androne A.S., Hryniewicz K., Goldsmith R., Arwady A., Katz S.D. Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure. Heart 2003, 89:854-858.
3. Behling A., Moraes R.S., Rohde L.E., Ferlin E.L., Nóbrega A.C., Ribeiro J.P. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure. Am. Heart J. 2003, 146:494-500.
4. Bibevski S., Dunlap M.E. Ganglionic mechanisms contribute to diminished vagal control in heart failure. Circulation 1999, 99:2958-2963.
5. Bibevski S., Dunlap M.E. Evidence for impaired vagus nerve activity in heart failure. Heart Fail. Rev. 2011, 16:129-135.
6. Chen J.S., Wang W., Bartholet T., Zucker I.H. Analysis of baroreflex control of heart rate in conscious dogs with pacing-induced heart failure. Circulation 1991, 83:260-267.
7. De Ferrari G.M., Crijns H.J., Borggrefe M., Milasinovic G., Smid J., Zabel M., Gavazzi A., Sanzo A., Dennert R., Kuschyk J., Raspopovic S., Klein H., Swedberg K., Schwartz P.J., CardioFit Multicenter Trial Investigators Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur. Heart J. 2011, 32:847-855.
8. De Pontes P.V., Bastos B.G., Romeo Filho L.J., Mesquita E.T., Nóbrega A.C. Cholinergic stimulation with pyridostigmine, hemodynamic and echocardiographic analysis in healthy subjects. Arq. Bras. Cardiol. 1999, 72:297-306.
9. Dewland T.A., Androne A.S., Lee F.A., Lampert R.J., Katz S.D. Effect of acetylcholinesterase inhibition with pyridostigmine on cardiac parasympathetic function in sedentary adults and trained athletes. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H86-H92.
10. Dibner-Dunlap M.E., Thames M.D. Baroreflex control of renal sympathetic nerve activity is preserved in heart failure despite reduced arterial baroreceptor sensitivity. Circ. Res. 1989, 65:1526-1535.
11. Du Y., Huang X., Wang T., Han K., Zhang J., Xi Y., Wu G., Ma A. Downregulation of neuronal sodium channel subunits Nav1.1 and Nav1.6 in the sinoatrial node from volume-overloaded heart failure rat. Pflugers Arch. 2007, 454:451-459.
12. Dunlap M.E., Bibevski S., Rosenberry T.L., Ernsberger P. Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H1632-H1640.
13. Eckberg D.L., Drabinsky M., Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N. Engl. J. Med. 1971, 285:877-883.
14. Floras J.S. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J. Am. Coll. Cardiol. 2009, 54:375-385.
15. Gaemperli O., Liga R., Spyrou N., Rosen S.D., Foale R., Kooner J.S., Rimoldi O.E., Camici P.G. Myocardial beta-adrenoceptor down-regulation early after infarction is associated with long-term incidence of congestive heart failure. Eur. Heart J. 2010, 31:1722-1729.
16. Henze M., Hart D., Samarel A., Barakat J., Eckert L., Scrogin K. Persistent alterations in heart rate variability, baroreflex sensitivity, and anxiety-like behaviors during development of heart failure in the rat. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H29-H38.
17. Jardine D.L., Charles C.J., Melton I.C., May C.N., Forrester M.D., Frampton C.M., Bennett S.I., Ikram H. Continual recordings of cardiac sympathetic nerve activity in conscious sheep. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:H93-H99.
18. Jose A.D., Taylor R.R. Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man. J. Clin. Invest. 1969, 48:2019-2031.
19. Kar S., Gao L., Belatti D.A., Curry P.L., Zucker I.H. Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failure. Hypertension 2011, 58:627-634.
20. Kashihara K. Roles of arterial baroreceptor reflex during Bezold-Jarisch reflex. Curr. Cardiol. Rev. 2009, 5:263-267.
21. Kassis E., Amtorp O. Cardiovascular and neurohumoral postural responses and baroreceptor abnormalities during a course of adjunctive vasodilator therapy with felodipine for congestive heart failure. Circulation 1987, 75:1204-1213.
22. Kassis E., Jacobsen T.N., Mogensen F., Amtorp O. Sympathetic reflex control of skeletal muscle blood flow in patients with congestive heart failure: evidence for beta-adrenergic circulatory control. Circulation 1986, 74:929-938.
23. Kingwell B.A., Thompson J.M., Kaye D.M., McPherson G.A., Jennings G.L., Esler M.D. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 1994, 90:234-240.
24. Krayer O. The history of the Bezold-Jarisch reflex. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmacol. 1961, 240:361-368.
25. La Rovere M.T., Bigger J.T., Marcus F.I., Mortara A., Schwartz P.J. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998, 351:478-484.
26. Li M., Zheng C., Sato T., Kawada T., Sugimachi M., Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 2004, 109:120-124.
27. Liang C.S. Cardiac sympathetic nerve terminal function in congestive heart failure. Acta Pharmacol. Sin. 2007, 28:921-927.
28. Liu J.L., Zucker I.H. Regulation of sympathetic nerve activity in heart failure: a role for nitric oxide and angiotensin II. Circ. Res. 1999, 84:417-423.
29. Luz P.L., Shubin H., Weil M.H., Jacobson E., Stein L. Pulmonary edema related to changes in colloid osmotic and pulmonary artery wedge pressure in patients after acute myocardial infarction. Circulation 1975, 51:350-357.
30. Meyrelles S.S., Bernardes C.F., Modolo R.P., Mill J.G., Vasquez E.C. Bezold-Jarisch reflex in myocardial infarcted rats. J. Auton. Nerv. Syst. 1997, 63:144-152.
31. Montano N., Ruscone T.G., Porta A., Lombardi F., Pagani M., Malliani A. Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation 1994, 90:1826-1831.
32. Murdoch C.E., Zhang M., Cave A.C., Shah A.M. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc. Res. 2006, 71:208-215.
33. Nobrega A.C., Dos Reis A.F., Moraes R.S., Bastos B.G., Ferlin E.L., Ribeiro J.P. Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects. Clin. Auton. Res. 2001, 11:11-17.
34. Pacher P., Nagayama T., Mukhopadhyay P., Bátkai S., Kass D.A. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat. Protoc. 2008, 3:1422-1433.
35. Pagani M., Lombardi F., Guzzetti S., Rimoldi O., Furlan R., Pizzinelli P., Sandrone G., Malfatto G., Dell'Orto S., Piccaluga E., Turiel M., Baselli G., Cerutti S., Malliani A. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ. Res. 1986, 59:178-193.
36. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., Fletcher P.J., Spadaro J., Kloner R.A., Braunwald E. Myocardial infarct size and ventricular function in rats. Circ. Res. 1979, 44:503-512.
37. Ponikowski P., Anker S.D., Chua T.P., Szelemej R., Piepoli M., Adamopoulos S., Webb-Peploe K., Harrington D., Banasiak W., Wrabec K., Coats A.J. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 1997, 79:1645-1650.
38. Rocha I., Rosário L.B., de Oliveira E.I., Barros M.A., Silva-Carvallho L. Enhancement of carotid chemoreceptor reflex and cardiac chemosensitive reflex in the acute phase of myocardial infarction of the anesthetized rabbit. Basic Res. Cardiol. 2003, 98:175-180.
39. Schultz H.D., Li Y.L. Carotid body function in heart failure. Respir. Physiol. Neurobiol. 2007, 157:171-185.
40. Serra S.M., Costa R.V., Castro R.R.T., Xavier S.S., Nóbrega A.C. Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure. J. Card. Fail. 2009, 15:124-129.
41. Singh K., Xiao L., Remondino A., Sawyer D.B., Colucci W.S. Adrenergic regulation of cardiac myocyte apoptosis. J. Cell. Physiol. 2001, 189:257-265.
42. Soares P.P.S., Nóbrega A.C.L., Ushizima M.R., Irigoyen M.C.C. Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats. Auton. Neurosci. 2004, 113:24-31.
43. Stauss H.M. Identification of blood pressure control mechanisms by power spectral analysis. Clin. Exp. Pharmacol. Physiol. 2007, 34:362-368.
44. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur. Heart J. 1996, 17:354-381.
45. Thomas G.D. Neural control of the circulation. Adv. Physiol. Educ. 2011, 35:28-32.
46. Thrasher T.N. Baroreceptors, baroreceptor unloading, and the long-term control of blood pressure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288:R819-R827.
47. Tobaldini E., Porta A., Wei S.G., Zhang Z.H., Francis J., Casali K.R., Weiss R.M., Felder R.B., Montano N. Symbolic analysis detects alterations of cardiac autonomic modulation in congestive heart failure rats. Auton. Neurosci. 2009, 150:21-26.
48. Wang W., Chen J.S., Zucker I.H. Carotid sinus baroreceptor reflex in dogs with experimental heart failure. Circ. Res. 1991, 68:1294-1301.
49. Zhang Y., Popovic Z.B., Bibevski S., Fakhry I., Sica D.A., Van Wagoner D.R., Mazgalev T.N. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ. Heart Fail. 2009, 2:692-699.
50. Zheng C., Li M., Inagaki M., Kawada T., Sunagawa K., Sugimachi M. Vagal stimulation markedly suppresses arrhythmias in conscious rats with chronic heart failure after myocardial infarction. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2005, 7:7072-7075.
51. Zhu G.Q., Zucker I.H., Wang W. Central AT1 receptors are involved in the enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure. Basic Res. Cardiol. 2002, 97:320-326.
52. Zucker I.H. Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension 2006, 48:1005-1011.
53. Zucker I.H., Patel K.P., Schultz H.D. Neurohumoral stimulation. Heart Fail. Clin. 2012, 8:87-99.